“Read the email to the jury,” the lawyer says.
My hands are shaking. I don’t look down at the page, because I already know every word.
The denial rate needs to hit forty percent by end of quarter.
That sentence killed a nine-year-old boy.
Eight months earlier, none of us knew this document existed.
I’ve worked as a social worker at Riverside Children’s for twelve years. I sit with families on the worst day of their lives and help them fight insurance companies for medicine their kids need to live. Mateo Delgado was seven months into leukemia treatment when his oncologist ordered a CAR-T infusion, his last real shot. His mother Rosa asked me to sit in on the call.
“Elena, stay on the line,” Rosa said. “I don’t trust myself not to yell.”
The rep read us a script. Denied. Experimental. Not medically necessary.
Mateo was in the bed behind us, hooked to a pole of fluids, listening to every word.
That night he told me something I brushed off.
“The lady laughed,” he said. “When Mommy asked about the medicine.”
Kids exaggerate on steroids. I told him it was probably nothing.
A few days later he said it again, with a new detail. “She said my doctor never even looked at my folder.”
That one stayed with me.
I pulled the denial letter and checked the name on it, the physician listed as “peer reviewer.” Family medicine. Retired six years. Never board-certified in oncology, ever.
Then I found two more denials in other families’ files, same name, same paragraph, word for word.
The hospital’s patient advocate told me to file a formal appeal and wait.
We didn’t have six weeks.
Mateo relapsed while the appeal sat on someone’s desk. By the time the insurance company finally approved the treatment, his body couldn’t take it.
He died on a Tuesday morning, Rosa holding one hand, me holding the other.
The lawsuit took a year to reach trial. Discovery turned up the memo – forty percent, end of quarter, corporate directive – the same week we learned that “reviewer” had denied over three hundred claims in a single month.
So when the lawyer asks me to read it out loud, I read it out loud.
“He approved a denial every four minutes,” I say. “He never opened Mateo’s chart. He never opened anyone’s.”
Rosa is crying in the front row.
The insurance company’s lawyer stands to object, but the judge tells him to sit back down.
Then a woman in the back of the courtroom stands up too.
“That same doctor denied my daughter last month,” she says. “She’s still alive. For now.”
The Woman in the Back
The courtroom goes quiet. Not the quiet of reverence – the quiet of a room full of people holding their breath.
Her name is Yvonne Okonkwo. Her daughter Amara is six, diagnosed with a rare lymphoma six months ago. Same insurance company. Same reviewer. Same form letter. Amara’s oncologist ordered a targeted therapy that gives her a seventy percent chance. The denial came back in three days.
I watch the judge. She’s older, gray hair in a tight bun, face like she’s seen it all. But her jaw tightens. She looks at the insurance company’s lawyer.
“Counsel, is this true?”
He’s already on his feet. “Your Honor, we’re talking about a different case – “
“It’s the same doctor,” Yvonne says. She’s still standing, one hand gripping the wooden pew in front of her. “The same three paragraphs. I have the letter in my purse.”
Our lawyer, a woman named Bethany Cross who has been doing medical malpractice for twenty years, turns around slowly. She looks at Yvonne like she’s been handed a gift she didn’t ask for.
“Your Honor, we’d like to enter that letter into evidence.”
The insurance company’s lawyer objects. Relevance. Prejudice. The judge overrules him in three words: “I’ll allow it.”
Yvonne walks to the front, heels clicking on the tile. She hands the folded letter to Bethany, who unfolds it, reads it silently, and then passes it to me.
“Ms. Reyes, is this the same language you saw in Mateo Delgado’s denial?”
I don’t need to look. But I look anyway. Same header. Same paragraph structure. Same signature stamp – Dr. Lawrence Keating, M.D., Peer Review Services. The date is June of this year. Four months after Mateo died.
“Yes.”
Bethany turns to the jury. Twelve faces. Some are trying to keep it together. An older man in the back row, bald, glasses, is gripping his armrest like it might fly away.
“This review took Dr. Keating how long to approve, Ms. Reyes?”
“Unknown. But in discovery, we learned his average review time was three minutes and forty-seven seconds per case. He was paid by the review. He submitted over three hundred denials in February alone.”
“And did he ever open a single medical chart for any of those three hundred patients?”
“No.”
The word sinks. Someone in the jury box whispers something. The bailiff doesn’t correct them.
Yvonne is still standing, arms crossed, shoulders tight. “Her next appointment is Thursday. They’ll call her incurable if we wait.”
Bethany asks the judge for a recess. She has a new witness.
Four Minutes Per Life
I’ve been sitting with this for a year. I know the numbers. But hearing them in a courtroom, under oath, hearing the deposition tapes played back – it’s different.
Dr. Keating’s deposition was taken three months before trial. They played it for the jury yesterday. His voice is thin, a little hoarse, like a man who’s spent his retirement on the golf course and resents being pulled away.
“And how many peer reviews do you perform in a typical week, Dr. Keating?”
“It varies.”
“Would you say seventy, eighty?”
“Probably closer to a hundred.”
“And for each review, you assess the patient’s full medical history?”
Pause. “I review the documentation provided.”
“You review the documentation. Do you ever request the actual chart?”
“No.”
“Do you ever speak to the treating physician?”
“No.”
“Do you ever see the patient?”
“No.”
“So for a hundred patients a week, you’re making life-and-death decisions based on a summary written by an insurance company claims adjuster?”
“That’s the process.”
The process. The memo, the one I read out loud, was written by a VP of claims named Dennis Pritchard. Subject line: Q3 Utilization Management Targets. Body: The denial rate needs to hit forty percent by end of quarter. Attached: a spreadsheet showing each reviewer’s current denial percentage. Keating’s was at thirty-two percent. Yellow-highlighted. Needs improvement.
Our team found five reviewers with similar targets. Keating was the most efficient. He had a rhythm. The claims would appear on his screen, he’d click through the summary, hit a pre-written denial template, and move on. Three minutes forty-seven seconds. I read that in his deposition too. He said it without shame. Just a metric.
Mateo’s claim took four minutes. The reviewer noted that the requested CAR-T therapy was “not standard of care” for pediatric leukemia. It had been FDA-approved for eighteen months.
I was in the room when Rosa got the denial. The nurse brought in a portable phone and we all sat around Mateo’s bed. His face was puffy from steroids. He was drawing on a napkin – a dinosaur, I think. The rep read the words. Rosa started crying. Mateo put down his crayon.
“Mommy, is the medicine not coming?”
The lady laughed. I didn’t hear it – the phone was on speaker, and Rosa was sobbing – but Mateo did. He told me later, that night, when I went back to check on them. He said, “The lady laughed, and then she said the doctor didn’t even read my folder.”
I thought he misheard. Kids shouldn’t have to be that accurate.
But he was.
We subpoenaed the call recordings. The rep, a woman named Cheryl, laughed after reading the denial. Someone in the background – probably a cubicle mate – had told a joke. She covered the receiver, but not well enough. Then she said, “Honestly, the doctor never even looked at this one. It’s sad.”
That recording is sealed. We’re not allowed to play it in court – some settlement agreement with the call center. But I’ve heard it. Three times.
Mateo heard it once. He was nine.
The Doctor Who Never Looked
Dr. Keating is not in the courtroom. He was never deposed in person – his lawyers sent a videographer to Florida. He’s seventy-four, a former family doc who retired after a back surgery and needed income. The company recruited him with an ad in a medical journal: “Earn Extra Income from Home. Peer Review Specialists Needed.” He applied online. They trained him in two hours. Six-figure income the first year.
I don’t hate him. That’s the part that keeps me up. He’s a cog. He didn’t set the target. He just did what he was paid to do. Probably told himself he was screening out unnecessary treatments. Probably didn’t think about the faces.
But the forty percent memo – that’s not a cog. That’s a strategy. Dennis Pritchard, the VP, has a corner office in Atlanta. In his deposition, he said the target was “aggressive but achievable.” He said the company was losing money on high-cost claims. He said the review process was “clinically sound.”
When asked if he’d ever met a single patient whose claim was denied, he said, “That’s not my role.”
Bethany had him read the memo aloud in his deposition. The transcript shows he didn’t flinch. Just read it like a grocery list.
Now Bethany is back in front of the jury, holding the memo on a blown-up foam board. She asks me to read it again.
“The denial rate needs to hit forty percent by end of quarter.”
“What does that mean to you, Ms. Reyes?”
I look at the jury. The bald man is wiping his eyes. A woman in the front row is scribbling notes, her pen moving fast.
“It means out of every ten children who needed medicine, four had to be told no. Even if the medicine would save them. Even if their doctor begged. Because a spreadsheet said forty percent.”
“And what happened to Mateo Delgado because of that forty percent?”
I can’t say it. My throat closes.
Rosa says it from the front row. “He died.”
The Lawyering
The judge calls a recess after that. We spill into the hallway. Yvonne is on the phone, crying, telling someone – her husband, I think – that they’re adding her to the case. Bethany is talking to a paralegal about an emergency injunction to stay Amara’s denial. I stand against the wall, cold tile on my back.
A man in a suit steps out of the courtroom. Defense counsel, a guy named Travers who has been staring at me all week like I’m a stain on his shoe. He walks up to Bethany.
“We’re prepared to discuss settlement.”
Bethany doesn’t look up from her phone. “I’m listening.”
“For the Delgado case. No admission of liability. Seven figures.”
“And Amara Okonkwo?”
Silence.
“Thought so.” She pockets her phone. “I’ll see you inside.”
We go back in. The judge is grim. She addresses the jury before the next witness.
“Ladies and gentlemen, you’re about to hear from Yvonne Okonkwo. I remind you that the law limits what you may consider, but I also remind you that your role here is to render justice based on the facts. Not sympathy. Justice.”
Yvonne takes the stand. Her voice is stronger than mine was. She describes Amara – her laugh, her love of pink tutus, the way she handles needles like a champ. Then she describes the denial letter. The same words. The same doctor. The same target.
Her daughter’s treatment, she says, costs $241,000. The insurance company saves that by denying it. If she dies.
“And if she gets the treatment?”
“She lives.”
Travers objects. Calls it speculation. The judge overrules.
Then Yvonne looks right at the jury and says, “I’m here because a memo told a retired doctor to say no four out of ten times. My daughter drew the unlucky number.”
The courtroom is weeping. Not loud. Just a roomful of people breathing through tears.
And I think about Mateo. About his dinosaur drawing. I still have it – a napkin with a green stegosaurus. He gave it to me the morning he died, said it was to protect me.
I keep it in my pocket. Every day.
The Settlement
The trial ends on a Thursday. Not with a verdict – the company settles. Three hours after Yvonne’s testimony, Travers announces they’ve reached an agreement. The terms are sealed, but Bethany tells me later it’s enough for Rosa to never work again. Amara gets her treatment approved by court order, same day. The company also agrees to an independent audit of its peer review practices.
But Dr. Keating still has his license. Dennis Pritchard still has his corner office. The forty percent memo becomes a footnote in an SEC filing. No one goes to jail.
I drive home that night, windows down, on the 5 freeway. The sun is setting orange and pink, and I’m thinking about the other three hundred kids. The ones whose parents didn’t have a social worker who noticed the same name on three denials. The ones who died before the memo ever saw a courtroom.
The ones who are still waiting.
I pull into my driveway. My own son, Isaac, is eight. He’s on the porch with a soccer ball. He waves. I wave back.
Inside, I check my work email. Habit. There’s a new denial notification from a family I met last week. Same insurance company. A toddler with a metabolic disorder. The denial is three paragraphs. I scroll to the bottom.
Peer Reviewer: Dr. L. Keating, M.D.
I close the laptop. I’ll call the lawyer in the morning. I’ll file the appeal. I’ll do it all over again.
Because the memo is still out there. Not just one memo – a whole culture. A system that writes forty percent into policy and calls it care.
Mateo gave me a stegosaurus to protect me. I don’t think I’m the one who needs protecting.
But I’ll carry it anyway.
I pick up the phone.
If this story stayed with you, share it. Someone you know is fighting this right now.
For more tales of moral quandaries in the medical field, consider reading Am I wrong for reporting my partner after what happened at the nursing home? or The Man Pinned in That Wreck Called Me By My Mother’s Name, and for a different kind of unsettling medical encounter, check out My Dad’s Nurse Wasn’t on the Schedule. Security Was Already on the Way..
